One dose of protein-targeting CAR-T cells shrinks solid tumors in preclinical tests
October 13, 2026
CAR-T cell therapies have fundamentally transformed the treatment of several blood and lymph node cancers.
CAR-T cell therapies have fundamentally transformed the treatment of several blood and lymph node cancers.
When Dr. Kourosh Parham conceived a first-of-its-kind blood test for tinnitus, he knew further research was needed to confirm a link between a unique ear protein and the common hearing disorder. To validate his theory, the professor of surgery at UConn Health (UCH), Division of Otolaryngology-Head & Neck Surgery, teamed up with fellow UCH physician-scientists to conduct two clinical trials.
Urolution Medical is preparing comparative clinical trials to evaluate catheter performance and patient outcomes.
A research team led by professor Chan Kui-ming from the Department of Biomedical Sciences at CityUHK discovered that H2BE113K, a missense H2B mutation, promotes colony formation and lung metastasis in breast cancer.
In a new study, Broad Institute researchers report that two small-molecule chemicals that reduce oxygen delivery to cells improved symptoms of neurodegeneration in a mouse model of Parkinson’s disease.
Northwestern Medicine scientists have identified a stem-like state in small-cell lung cancer that distinguishes a group of patients with exceptionally poor outcomes following chemoimmunotherapy, according to a study published in Cell Reports Medicine.
Diseases such as Alzheimer’s and frontotemporal dementia are considered neurodegenerative tauopathies, in which tau proteins in the brain misfold and lead to cognitive decline. Until now, it has been unclear how misfolded tau recruits other seemingly healthy tau and causes it to misfold and clump.
Johns Hopkins University engineers have created robots the size of a pencil tip intended to travel through the body to deliver medicine to infections inside a beating heart.
Stopping a cancer cell from dividing does not necessarily make it harmless. Chemotherapy can leave behind living, senescent cells. These ‘zombie’ cells can release inflammatory signals, helping tumors resist treatment. Drugs that eliminate these lingering cells could help, but they can also harm other cells.
RANCHO CUCAMONGA, Calif., Oct. 6, 2026 /PRNewswire/ — New World Medical is pleased to announce the Ahmed® Glaucoma Valve (AGV), Ahmed ClearPath® (ACP), and KDB GLIDE® have received Medical Device Regulation (MDR) certification in the European Union.